EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis

Helena Castañé, Andrea Jiménez-Franco iD, Cristian Martínez-Navidad, Cristina Placed-Gallego, Vicente Cambra-Cortés, Adelina-Miruna Perta, Marta París iD, Daniel Del Castillo, Meritxell Arenas iD, Jordi Camps iD, Jorge Joven iD

Antioxidants · 23.11.2023 · 12 (12) · 2038

DOI: 10.3390/antiox12122038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antioxidants, online erschienen am 23.11.2023. Verfasst von Helena Castañé und 10 weiteren Autor:innen. Beteiligte Einrichtung: Unitat de Recerca Biomédica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Government of Catalonia, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paraoxonase-1 (PON1) is an antioxidant enzyme associated with high-density lipoproteins (HDL). Reduced serum PON1 activity is found in diseases marked by oxidative stress and inflammation, but its role in obesity remains unclear. This study investigated PON1 activities and concentrations in morbidly obese individuals and explored the impacts of the genetic polymorphism PON1 rs662 and non-alcoholic fatty liver disease on enzymatic properties. We recruited 1349 morbidly obese patients undergoing bariatric surgery and 823 non-obese volunteers. PON1-related variables, including arylesterase, paraoxonase, and lactonase activities and PON1 concentrations, were examined. Our results showed that morbidly obese individuals exhibited higher PON1 concentrations but lower enzymatic activities than non-obese individuals. We observed inverse associations of arylesterase and paraoxonase activities with waist circumference (rho = −0.24, p < 0.001, and rho = −0.30, p < 0.001, respectively) and body mass index (rho = −0.15, p = 0.001, and rho = −0.23, p < 0.001), as well as direct associations of arylesterase, paraoxonase, and lactonase activities with HDL cholesterol (rho = 0.11, p = 0.005, rho = 0.20, p < 0.001, and rho = 0.20, p < 0.001). No significant differences were observed regarding metabolic syndrome, type 2 diabetes mellitus, hypertension, dyslipidemia, rs662 polymorphism allele frequencies, or the diagnosis of non-alcoholic steatohepatitis. Nevertheless, correlations were found between certain PON1-related variables, steatosis, and ballooning. In conclusion, changes in PON1-related variables in morbidly obese patients are dependent on the disease itself and HDL levels. The relationships between these variables and specific liver histological changes raise intriguing questions for consideration in future studies.

Schlagwörter

Stichwörter der Autor:innen

arylesteraselactonasemorbid obesitynon-alcoholic fatty liver diseasenon-alcoholic steatohepatitisobesityparaoxonase-1

Autor:innen und Institutionen

  • Unitat de Recerca Biomédica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.
  • Department of Bariatric Surgery, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.
  • Department of Radiation Oncology, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

ORCID-Profile: Andrea Jiménez-Franco, Marta París, Meritxell Arenas, Jordi Camps, Jorge Joven

Förderung

  • Instituto de Salud Carlos III
  • Government of Catalonia
  • Ministerio de Ciencia e Innovación
  • Departament de Salut
  • Departament de Recerca i Universitats
  • Instituto de Salud Carlos III, Madrid, Spain
  • European Regional Development Fund [FEDER]
  • Generalitat de Catalunya, Barcelona, Spain

Zitieren

APA

Castañé, H., Jiménez-Franco, A., Martínez-Navidad, C., Placed-Gallego, C., Cambra-Cortés, V., Perta, A. M., París, M., Castillo, D. D., Arenas, M., Camps, J., & Joven, J. (2023). Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis. Antioxidants, 12(12), 2038. https://doi.org/10.3390/antiox12122038

Vancouver

Castañé H, Jiménez-Franco A, Martínez-Navidad C, Placed-Gallego C, Cambra-Cortés V, Perta AM, et al. Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis. Antioxidants. 2023;12(12):2038. doi:10.3390/antiox12122038

BibTeX
@article{Casta2023,
  author = {Castañé, Helena and Jiménez-Franco, Andrea and Martínez-Navidad, Cristian and Placed-Gallego, Cristina and Cambra-Cortés, Vicente and Perta, Adelina-Miruna and París, Marta and Castillo, Daniel Del and Arenas, Meritxell and Camps, Jordi and Joven, Jorge},
  title = {Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis},
  journal = {Antioxidants},
  year = {2023},
  volume = {12},
  number = {12},
  pages = {2038},
  doi = {10.3390/antiox12122038}
}
Kostenlos starten →